Literature DB >> 28269773

Impact of Recruitment Methods in Subjective Cognitive Decline.

Carla Abdelnour1, Octavio Rodríguez-Gómez1, Montserrat Alegret1, Sergi Valero2, Sonia Moreno-Grau1, Ángela Sanabria1, Isabel Hernández1, Maitee Rosende-Roca1, Liliana Vargas1, Ana Mauleón1, Domingo Sánchez1, Ana Espinosa1, Gemma Ortega1, Alba Pérez-Cordón1, Susana Diego1, Anna Gailhajanet1, Marina Guitart1, Óscar Sotolongo-Grau1, Agustín Ruiz1, Lluís Tárraga1, Mercè Boada1.   

Abstract

BACKGROUND: Recruitment methods can determine sample characteristics in mild cognitive impairment and Alzheimer's disease dementia, but little is known about its influence in subjective cognitive decline (SCD).
OBJECTIVE: To determine the influence of two types of recruitment methods in the characteristics of individuals with SCD.
METHODS: We select and compare clinical and neuropsychological features, and frequency of APOE ɛ4 allele of 326 subjects with SCD from two cohorts: Open House Initiative (OHI) versus Memory Unit (MU). A logistic regression analysis (LRA), using gender and years of education as covariates, was used to examine the neuropsychological variables.
RESULTS: The OHI sample were mostly women (75.9% versus 64.5%, p < 0.05), with higher educational level (12.15 [3.71] versus 10.70 [3.80] years, p = 0.001), and more family history of dementia (138 [62.7%] versus 44 [41.5%], p < 0.001) than the MU sample. Also, the OHI sample showed better overall neuropsychological performance than the MU sample, and after a LRA, this trend continued in automatic response inhibition capacity, abstract reasoning, and recognition memory. We did not find differences in age, depression history, and/or APOE ɛ4 allele frequency.
CONCLUSION: SCD subjects showed different demographic and neuropsychological characteristics depending on the recruitment method, which should be taken into account in the design of research studies with this target population.

Entities:  

Keywords:  Alzheimer’s disease; patient recruitment; research subject recruitment; sampling studies; subjective cognitive decline

Mesh:

Substances:

Year:  2017        PMID: 28269773     DOI: 10.3233/JAD-160915

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  15 in total

1.  Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.

Authors:  Rosalinde E R Slot; Sietske A M Sikkes; Johannes Berkhof; Henry Brodaty; Rachel Buckley; Enrica Cavedo; Efthimios Dardiotis; Francoise Guillo-Benarous; Harald Hampel; Nicole A Kochan; Simone Lista; Tobias Luck; Paul Maruff; José Luis Molinuevo; Johannes Kornhuber; Barry Reisberg; Steffi G Riedel-Heller; Shannon L Risacher; Susanne Roehr; Perminder S Sachdev; Nikolaos Scarmeas; Philip Scheltens; Melanie B Shulman; Andrew J Saykin; Sander C J Verfaillie; Pieter Jelle Visser; Stephanie J B Vos; Michael Wagner; Steffen Wolfsgruber; Frank Jessen; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

2.  The Impact of Study Setting on Clinical Characteristics in Older Chinese Adults with Subjective Cognitive Decline: Baseline Investigation of Convenience and Population-Based Samples.

Authors:  Mingyan Zhao; Guanqun Chen; Taoran Li; Can Sheng; Yuxia Li; Ying Han
Journal:  Biomed Res Int       Date:  2021-06-04       Impact factor: 3.411

3.  Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.

Authors:  Bjørn-Eivind Kirsebom; Ragna Espenes; Knut Waterloo; Erik Hessen; Stein Harald Johnsen; Geir Bråthen; Dag Aarsland; Tormod Fladby
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.

Authors:  Mercè Boada; Miguel A Santos-Santos; Octavio Rodríguez-Gómez; Montserrat Alegret; Pilar Cañabate; Asunción Lafuente; Carla Abdelnour; Mar Buendía; Maria José de Dios; América Morera; Ángela Sanabria; Laura Campo; Agustín Ruiz; Lluís Tárraga
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Subjective cognitive and non-cognitive complaints and brain MRI biomarkers in the MEMENTO cohort.

Authors:  Virginie Dauphinot; Vincent Bouteloup; Jean-François Mangin; Bruno Vellas; Florence Pasquier; Frédéric Blanc; Olivier Hanon; Audrey Gabelle; Cédric Annweiler; Renaud David; Vincent Planche; Olivier Godefroy; Thérèse Rivasseau-Jonveaux; Marie Chupin; Clara Fischer; Geneviève Chêne; Carole Dufouil; Pierre Krolak-Salmon
Journal:  Alzheimers Dement (Amst)       Date:  2020-07-05

6.  Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).

Authors:  Itziar de Rojas; J Romero; O Rodríguez-Gomez; P Pesini; A Sanabria; A Pérez-Cordon; C Abdelnour; I Hernández; M Rosende-Roca; A Mauleón; L Vargas; M Alegret; A Espinosa; G Ortega; S Gil; M Guitart; A Gailhajanet; M A Santos-Santos; Sonia Moreno-Grau; O Sotolongo-Grau; S Ruiz; L Montrreal; E Martín; E Pelejà; F Lomeña; F Campos; A Vivas; M Gómez-Chiari; M A Tejero; J Giménez; V Pérez-Grijalba; G M Marquié; G Monté-Rubio; S Valero; A Orellana; L Tárraga; M Sarasa; A Ruiz; M Boada
Journal:  Alzheimers Res Ther       Date:  2018-11-29       Impact factor: 6.982

7.  Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort.

Authors:  Gonzalo Sánchez-Benavides; Oriol Grau-Rivera; Marc Suárez-Calvet; Carolina Minguillon; Raffaele Cacciaglia; Nina Gramunt; Carles Falcon; Juan Domingo Gispert; José Luis Molinuevo
Journal:  Alzheimers Res Ther       Date:  2018-12-20       Impact factor: 6.982

8.  Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline.

Authors:  Ragna Espenes; Bjørn-Eivind Kirsebom; Cecilia Eriksson; Knut Waterloo; Erik Hessen; Stein Harald Johnsen; Per Selnes; Tormod Fladby
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative.

Authors:  Marta Marquié; Sergi Valero; Miguel Castilla-Marti; Joan Martínez; Octavio Rodríguez-Gómez; Ángela Sanabria; Juan Pablo Tartari; Gemma C Monté-Rubio; Oscar Sotolongo-Grau; Montserrat Alegret; Alba Pérez-Cordón; Natalia Roberto; Itziar de Rojas; Sonia Moreno-Grau; Laura Montrreal; Isabel Hernández; Maitee Rosende-Roca; Ana Mauleón; Liliana Vargas; Carla Abdelnour; Silvia Gil; Ester Esteban-De Antonio; Ana Espinosa; Gemma Ortega; Francisco Lomeña; Javier Pavia; Assumpta Vivas; Miguel Ángel Tejero; Marta Gómez-Chiari; Rafael Simó; Andreea Ciudin; Cristina Hernández; Adelina Orellana; Alba Benaque; Agustín Ruiz; Lluís Tárraga; Mercè Boada
Journal:  Alzheimers Res Ther       Date:  2020-03-31       Impact factor: 6.982

Review 10.  Functional neuroimaging in subjective cognitive decline: current status and a research path forward.

Authors:  Raymond P Viviano; Jessica S Damoiseaux
Journal:  Alzheimers Res Ther       Date:  2020-03-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.